The Venture Codex Logo

The Venture Codex

Aditum

1111 Broadway, Suite 1300, Oakland, California, 94607, United States

Overview

Investment fund acquiring and developing pharmaceutical assets.

Founded

2019

Deals ยท 12mo

1

Links

WebsiteLinkedIn

Stage focus

Seed
Series A
Series B

Geographic focus

United Arab Emirates
United States

Sector focus

Health Care
Medical
Therapeutics
Venture Capital

Investment portfolio

6rounds
NAMEDATESIZE
Oblenio Bio
Jun 2026Participated
$62 MSeries B
Tempero Bio
Mar 2025Participated
$70 MSeries B
qeen.ai
Jun 2024Participated
$2 MSeed
Hubpay
Feb 2022Participated
$20 MSeries A
Via Nova Therapeutics
Sep 2021Led
$20 MSeries A
Versanis Bio
Aug 2021Participated
$70 MSeries A
Oblenio Bio
Jun 2026Participated
$62 MSeries B
Tempero Bio
Mar 2025Participated
$70 MSeries B
qeen.ai
Jun 2024Participated
$2 MSeed
Hubpay
Feb 2022Participated
$20 MSeries A
Via Nova Therapeutics
Sep 2021Led
$20 MSeries A
Versanis Bio
Aug 2021Participated
$70 MSeries A
6
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Aditum: 6 funding rounds are recorded in the selected participation categories.All available history.
Aditum: 6 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A12
Series B02

Monthly Deal Activity

Aditum: 6 deals are recorded across 63 months.All available history.
Aditum: 6 deals are recorded across 63 months. All available history
MonthDeals
Aug '211
Sep '211
Oct '210
Nov '210
Dec '210
Jan '220
Feb '221
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '251
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '261
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Aditum: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Aditum: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4
Fintech1
Manufacturing1
AI & Machine Learning1

Deal Size Distribution

Aditum: 6 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Aditum: 6 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M2
$25M-$50M0
$50M-$100M3
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Aditum: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Aditum: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
United Arab Emirates2
Aditum: 18 co-investors are shown, with 10x Founders sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Aditum: 18 co-investors are shown, with 10x Founders sharing 1 recorded deals. All available history
Co-investorShared deals
10x Founders1
8VC1
Atlas Venture1
BECO Capital1
Dara Holdings1
Deep Track Capital1
Emkan Capital1
Eureka 4601
Google Ventures1
Jabbar Internet Group1
Khosla Ventures1
Medicxi1
Olive Tree Capital1
Pfizer Ventures1
Phaze Ventures1
Signal Peak Ventures1
Stormbreaker Ventures1
Wamda Capital1

Investment Strategy

Aditum: Led accounts for 17% and participating for 83% of round participation.All available history.
Aditum: Led accounts for 17% and participating for 83% of round participation. All available history
CategoryDeals (count)Share (%)
Led117%
Participating583%
Aditum: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Aditum: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Ilan Zipkin

Partner and VP, Business Development and Licensing

Joe Jimenez

Co-Founder and Managing Director

Josh Gertsman
Mark Fishman

Co-Founder and Chair of the Scientific Advisory BoardAditum Bio

Susie Phillips

Executive Assistant to Co-Founder and Managing Director